Feigan granules improve traditional Chinese medicine symptoms scale scores for influenza patients: a prospective clinical observational Study.

Q2 Medicine
Weihao Chen, Dongsheng Zheng, Shuangshuang DU, Qian Li, Guolin Wu, Dongsheng Hong, Qingwei Zhao
{"title":"Feigan granules improve traditional Chinese medicine symptoms scale scores for influenza patients: a prospective clinical observational Study.","authors":"Weihao Chen, Dongsheng Zheng, Shuangshuang DU, Qian Li, Guolin Wu, Dongsheng Hong, Qingwei Zhao","doi":"10.3724/zdxbyxb-2024-0559","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the clinical efficacy of hospital-prepared Chinese medicine Feigan granules for influenza patients.</p><p><strong>Methods: </strong>A prospective observational study was conducted on influenza patients who visited the Fever Clinic of the First Affiliated Hospital, Zhejiang University School of Medicine between February 2024 and March 2024 were enrolled. Patients were divided into an observation group (Feigan granules combined with conventional Western medicine) and a control group (conventional Western medicine) based on whether they used Feigan granules. Main symptoms (including fever, cough and sore throat) and secondary symptoms (including chest tightness, poor appetite, muscle soreness and dry mouth) were evaluated with traditional Chinese medicine (TCM) symptom scale on the first day of the patient's visit and the third day after treatment. The degrees of improvement in the TCM symptom scores before and after treatment were compared using the paired rank-sum test, and the differences in the overall symptom efficacy index between two groups were compared using the Wilcoxon test.</p><p><strong>Results: </strong>A total of 217 influenza patients were included. After treatment, the TCM symptom scores of both groups were significantly improved compared with those before treatment (all <i>P</i><0.05). The median difference in the main symptom score before and after treatment in the study and the control groups was 7 points (95%<i>CI</i>: 6.0-8.0) and 6 points (95%<i>CI</i>: 6.0-8.0), respectively; the median difference in the secondary symptom score was 3 points (95%<i>CI</i>: 2.0-4.0) in both groups. The median difference in the total score was 9 points (95%<i>CI</i>: 8.0-10.5) and 8 points (95%<i>CI</i>: 7.0-10.0) in the study and control groups, respectively. In the subgroup with an initial cough score >2, the improvement rates of overall symptoms (97.06% <i>vs</i>. 92.59%) and secondary symptoms (92.31% <i>vs</i>. 85.11%) in study group were significantly higher than those in the control group (<i>P</i><0.05); while there was no significant difference in the improvement rate of main symptoms (95.59% <i>vs</i>. 90.74%, <i>P</i>>0.05).</p><p><strong>Conclusions: </strong>Feigan granules can improve the TCM syndromes of influenza patients, especially for patients with more severe cough.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3724/zdxbyxb-2024-0559","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To evaluate the clinical efficacy of hospital-prepared Chinese medicine Feigan granules for influenza patients.

Methods: A prospective observational study was conducted on influenza patients who visited the Fever Clinic of the First Affiliated Hospital, Zhejiang University School of Medicine between February 2024 and March 2024 were enrolled. Patients were divided into an observation group (Feigan granules combined with conventional Western medicine) and a control group (conventional Western medicine) based on whether they used Feigan granules. Main symptoms (including fever, cough and sore throat) and secondary symptoms (including chest tightness, poor appetite, muscle soreness and dry mouth) were evaluated with traditional Chinese medicine (TCM) symptom scale on the first day of the patient's visit and the third day after treatment. The degrees of improvement in the TCM symptom scores before and after treatment were compared using the paired rank-sum test, and the differences in the overall symptom efficacy index between two groups were compared using the Wilcoxon test.

Results: A total of 217 influenza patients were included. After treatment, the TCM symptom scores of both groups were significantly improved compared with those before treatment (all P<0.05). The median difference in the main symptom score before and after treatment in the study and the control groups was 7 points (95%CI: 6.0-8.0) and 6 points (95%CI: 6.0-8.0), respectively; the median difference in the secondary symptom score was 3 points (95%CI: 2.0-4.0) in both groups. The median difference in the total score was 9 points (95%CI: 8.0-10.5) and 8 points (95%CI: 7.0-10.0) in the study and control groups, respectively. In the subgroup with an initial cough score >2, the improvement rates of overall symptoms (97.06% vs. 92.59%) and secondary symptoms (92.31% vs. 85.11%) in study group were significantly higher than those in the control group (P<0.05); while there was no significant difference in the improvement rate of main symptoms (95.59% vs. 90.74%, P>0.05).

Conclusions: Feigan granules can improve the TCM syndromes of influenza patients, especially for patients with more severe cough.

肺肝颗粒改善流感患者中医症状量表评分:一项前瞻性临床观察研究
目的:评价医院配制的中药肺肝颗粒治疗流行性感冒的临床疗效。方法:对2024年2月至2024年3月在浙江大学医学院第一附属医院发热门诊就诊的流感患者进行前瞻性观察研究。根据患者是否使用肺肝颗粒分为观察组(肺肝颗粒联合西药)和对照组(西药)。于患者就诊第一天及治疗后第3天采用中医症状量表评估患者的主要症状(发热、咳嗽、喉咙痛)和次要症状(胸闷、食欲不振、肌肉酸痛、口干)。采用配对秩和检验比较治疗前后中医症状评分的改善程度,采用Wilcoxon检验比较两组患者整体症状疗效指标的差异。结果:共纳入流感患者217例。治疗后,两组中医症状评分均较治疗前(均PCI: 6.0 ~ 8.0)显著改善,分别改善6分(95%CI: 6.0 ~ 8.0);两组继发性症状评分中位差为3分(95%CI: 2.0 ~ 4.0)。研究组和对照组的总分中位差值分别为9分(95%CI: 8.0 ~ 10.5)和8分(95%CI: 7.0 ~ 10.0)。在初始咳嗽评分bbbb2的亚组中,研究组总症状(97.06% vs. 92.59%)和继发症状(92.31% vs. 85.11%)的改善率均显著高于对照组(P值为90.74%,P值为b> 0.05)。结论:肺感颗粒可改善流感患者的中医证候,尤其对咳嗽较重的患者疗效显著。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
67
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信